Key result
Transvenous transseptal antegrade TAVR was technically feasible in 8 of 9 inoperable patients with aortic stenosis and no other access options, with no cerebrovascular events at 6 months.
Why the study?
Is transvenous transseptal antegrade TAVR feasible in inoperable patients with aortic stenosis who have contraindications for other access approaches?
Population
9 inoperable patients with aortic stenosis who had contraindications for other access approaches, mean age…
Design
Case_series
Follow-up
6 months
Authors
Loading...
Supports antegrade TAVR feasibility in no-access patients; hypothesis-generating and requires prospective trials before clinical consideration.
Observational (n=9)
No
Is transvenous transseptal antegrade TAVR feasible in inoperable patients with aortic stenosis who have contraindications for other access approaches?
The transvenous transseptal antegrade approach to TAVR is a technically feasible option that can improve symptoms in inoperable patients with aortic stenosis who lack other access options.
Cohen et al. (2013) conducted an observational in Aortic stenosis (n=9). Transvenous transseptal antegrade transcatheter aortic valve replacement (TAVR) was evaluated on Technical feasibility of antegrade deployment. Transvenous transseptal antegrade TAVR was technically feasible in 8 of 9 inoperable patients with aortic stenosis and no other access options, with no cerebrovascular events at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: